<DOC>
	<DOCNO>NCT02476994</DOCNO>
	<brief_summary>This descriptive study design evaluate propensity hospitalize pediatric patient treat adequately Clinolipid standard care 90 day develop Essential Fatty Acid Deficiency ( EFAD ) . Additionally , study design evaluate safety efficacy use Clinolipid pediatric population .</brief_summary>
	<brief_title>Pediatric Study Evaluate Risk Developing Essential Fatty Acid Deficiency When Receiving Clinolipid Standard-of-Care Lipid Emulsion</brief_title>
	<detailed_description />
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>1 . Patients and/or legal representative must able understand study voluntarily sign ICF 2 . Patients age &lt; 18 year 3 . Patients able adhere protocol requirement 4 . Patients expect require PN least 7 day 5 . Premature infant ( &lt; 36 week gestation ) require least 80 % PN meet nutrition requirement study entry ; full term infant child require least 70 % PN meet nutrition requirement study entry 1 . Patients expect survive hospitalization severe illness foreseeable intercurrent event could jeopardize patient 's participation study 2 . Patients know hypersensitivity lipid emulsion , egg soybean protein , active substance , excipients , component container 3 . Patients diagnosis shock , renal failure require dialysis , severe metabolic acidosis ( eg , pH &lt; 7.10 , serum bicarbonate level â‰¤15 mEq/L , and/or Anion Gap &gt; 16 mEq/L ) 4 . Patients hemodynamic instability judge Investigator 5 . Patients uncorrected metabolic disorder ( eg , diabetes ) liver disease include cholestasis 6 . Patients severe hyperlipidemia severe disorder lipid metabolism characterize hypertriglyceridemia ( triglyceride &gt; 400 mg/dL ) 7 . Patients unable tolerate necessary laboratory monitoring 8 . Patients new active infection ( assessed investigator ) time initiation study treatment 9 . Patients enrol another clinical trial involve investigational agent 10 . Patients treat IV lipid within 48 hour randomization study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Essential Fatty Acids ( EFA )</keyword>
	<keyword>Parenteral Nutrition</keyword>
	<keyword>Clinolipid/Clinoleic</keyword>
	<keyword>Parenteral Nutrition Associated Cholestasis ( PNAC )</keyword>
	<keyword>Parenteral Nutrition Associated Liver Disease ( PNALD )</keyword>
	<keyword>Intestinal Failure Associated Liver Disease ( IFALD )</keyword>
	<keyword>Phytosterols</keyword>
	<keyword>Intralipid</keyword>
	<keyword>Infants/Preterm Infants</keyword>
	<keyword>FADS1 FADS2</keyword>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>Cancer Nutrition</keyword>
	<keyword>Olive Oil Emulsion</keyword>
	<keyword>Soybean Oil Emulsion</keyword>
</DOC>